- Home
- PLRX vs BRIA Comparison
PLRX vs BRIA Comparison
Compare PLRX & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- BRIA
- Stock Information
- Founded
- PLRX 2015
- BRIA 2011
- Country
- PLRX United States
- BRIA Singapore
- Employees
- PLRX N/A
- BRIA N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- BRIA
- Sector
- PLRX Health Care
- BRIA
- Exchange
- PLRX Nasdaq
- BRIA NYSE
- Market Cap
- PLRX 77.3M
- BRIA 62.0M
- IPO Year
- PLRX 2020
- BRIA 2024
- Fundamental
- Price
- PLRX $1.40
- BRIA $2.38
- Analyst Decision
- PLRX Hold
- BRIA
- Analyst Count
- PLRX 10
- BRIA 0
- Target Price
- PLRX $9.79
- BRIA N/A
- AVG Volume (30 Days)
- PLRX 1.6M
- BRIA 2.9K
- Earning Date
- PLRX 08-06-2025
- BRIA 08-15-2025
- Dividend Yield
- PLRX N/A
- BRIA N/A
- EPS Growth
- PLRX N/A
- BRIA N/A
- EPS
- PLRX N/A
- BRIA 92.24
- Revenue
- PLRX N/A
- BRIA $59,695,825.00
- Revenue This Year
- PLRX N/A
- BRIA N/A
- Revenue Next Year
- PLRX N/A
- BRIA N/A
- P/E Ratio
- PLRX N/A
- BRIA $0.03
- Revenue Growth
- PLRX N/A
- BRIA 8.03
- 52 Week Low
- PLRX $1.10
- BRIA $1.78
- 52 Week High
- PLRX $16.10
- BRIA $4.38
- Technical
- Relative Strength Index (RSI)
- PLRX 54.68
- BRIA N/A
- Support Level
- PLRX $1.13
- BRIA N/A
- Resistance Level
- PLRX $1.27
- BRIA N/A
- Average True Range (ATR)
- PLRX 0.11
- BRIA 0.00
- MACD
- PLRX 0.02
- BRIA 0.00
- Stochastic Oscillator
- PLRX 90.00
- BRIA 0.00
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.